Device Gastrointestinal Ai

Gi Genius

Payments companies reported to CMS as associated with Gi Genius. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$467Kassociated payments (2023-2025)
1,609clinicians with associated payments
1company reporting

By year

2023 $159K
2024 $196K
2025 $112K

Payments reported as associated with Gi Genius, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Gastroenterology (Internal Medicine) $420K
Internal Medicine $17K
Surgery $6,855
Colon & Rectal Surgery $3,392
Family $2,852
Nurse Practitioner $1,526

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Gi Genius

These are the largest totals companies reported as associated with Gi Genius. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Rajesh Keswani Saint Louis, MO Gastroenterology (Internal Medicine) $45,971.52
Tyler Berzin Boston, MA Gastroenterology (Internal Medicine) $33,231.82
Vasundhara Appalaneni Dayton, OH Gastroenterology (Internal Medicine) $23,455.21
Seth Gross New York, NY Gastroenterology (Internal Medicine) $23,186.85
Nirav Shah Wyomissing, PA Gastroenterology (Internal Medicine) $19,228.58
Douglas Rex Indianapolis, IN Gastroenterology (Internal Medicine) $14,453.13
Farah Monzur East Setauket, NY Gastroenterology (Internal Medicine) $13,000.00
Michael Wallace Jacksonville, FL Gastroenterology (Internal Medicine) $12,027.61
Jonathon Chapman Baton Rouge, LA Gastroenterology (Internal Medicine) $11,874.17
Jeremy Glissen Brown Durham, NC Gastroenterology (Internal Medicine) $10,939.48

Prescribed Gi Genius?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.